GLENMARK PHARMACEUTICALS LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,085 INR | +0.51% |
|
+4.31% | +26.96% |
| 06:09am | Glenmark Pharmaceuticals Gets US FDA's Final Approval for Generic Pain Relief Medicines | MT |
| Apr. 25 | Glenmark Lifesciences' Net Profit Slides in Fiscal Q4 | MT |
Quotes 5-day view
Delayed Quote NSE India S.E.| 2024-04-23 | 2024-04-24 | 2024-04-25 | 2024-04-26 | 2024-04-29 | |
|---|---|---|---|---|---|
| Last | 1034.5 ₹ | 1070.95 ₹ | 1080.3 ₹ | 1079.35 ₹ | 1,085 ₹ |
| Volume | 1 223 564 | 657 378 | 1 101 089 | 475 440 | 101 690 |
| Change | -0.47% | +3.52% | +0.87% | -0.09% | +0.51% |
| Opening | 1,039.35 | 1,036.00 | 1,071.00 | 1,085.00 | 1,090 |
| High | 1,044.25 | 1,074.60 | 1,096.00 | 1,088.75 | 1,091 |
| Low | 1,017.50 | 1,033.30 | 1,070.95 | 1,061.25 | 1,078 |
Performance
| 1 day | +0.44% | ||
| 1 week | +4.31% | ||
| Current month | +13.11% | ||
| 1 month | +10.35% | ||
| 3 months | +20.48% | ||
| 6 months | +44.52% | ||
| Current year | +26.96% | ||
| 1 year | +99.33% | ||
| 3 years | +91.43% | ||
| 5 years | +69.82% | ||
| 10 years | +84.90% |
Volumes
marketsDaily volume
101 690
Estimated daily volume
621 311
Avg. Volume 20 sessions
816 435
Daily volume ratio
0.76
Avg. Volume 20 sessions INR
885 750 331.50
Avg. Volume 20 sessions USD
10 621 032.23
Record volume 1
89 266 590
Record volume 2
65 123 680
Record volume 3
39 631 540
Capital turnover ratio
0.00
Float rotation
0.01
Basic data
Capitalization (INR)
304 572 774 998
Capitalization (USD)
3 652 132 145
Net sales (INR)
129 901 100 000
Net sales (USD)
1 557 644 090
Number of employees
15 556
Sales / Employee (INR)
8 350 546
Sales / Employee (USD)
100 131
Free-Float
49.03 %
Free-Float capitalization (INR)
149 344 166 556
Free-Float capitalization (USD)
1 790 785 901
Average Daily Capital Traded
0.29%
Highs and lows
1 week
1 017.50
1 096.00
1 month
959.051 096.00
Current year
771.001 096.00
1 year
536.251 096.00
3 years
348.501 096.00
5 years
161.651 096.00
10 years
161.651 262.90
Indicators
Moving average 5 days
1 060.89
Moving average 20 days
1 022.17
Moving average 50 days
950.65
Moving average 100 days
903.93
Price spread / (MMA5)
-2.21%
Price spread / (MMA20)
-5.78%
Price spread / (MMA50)
-12.37%
Price spread / (MMA100)
-16.68%
STIM
RSI 9 days
72.68
RSI 14 days
70.47
Sector Comparison - Generic Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +0.51% | +4.31% | +26.96% | +99.33% | 3.65B | ||
| +1.10% | -1.08% | +20.97% | +56.57% | 43.34B | ||
| +1.56% | +2.97% | +20.44% | +38.45% | 21.96B | ||
| -2.31% | +1.66% | +10.86% | - | 14.09B | ||
| -0.75% | +3.24% | +12.23% | +52.42% | 13.64B | ||
| +1.86% | +0.60% | +40.09% | +86.77% | 11.43B | ||
| 0.00% | +2.77% | -8.59% | -16.18% | 6.86B | ||
| -.--% | +0.14% | - | - | 6.79B | ||
| -.--% | -1.95% | - | - | 5.73B | ||
| +1.98% | +1.70% | +8.46% | +20.74% | 5.22B | ||
| +1.13% | +11.13% | -4.29% | -13.00% | 4.71B | ||
| +1.38% | +3.90% | +5.14% | +12.61% | 4.57B | ||
| +0.40% | -0.40% | +14.09% | +12.05% | 4.13B | ||
| +0.46% | -1.59% | +30.18% | +158.42% | 3.7B | ||
| +0.34% | +5.20% | +5.59% | +70.12% | 3.31B | ||
| +0.16% | +0.65% | -11.91% | -1.95% | 2.86B | ||
| Average | +0.49% | +2.25% | +12.16% | +44.33% | ||
| Weighted average by Cap. | +0.58% | +1.61% | +16.57% | +48.09% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
b651af0aac02f04c.zzHhgLVrTwXCDIRAsZP_vE3ExqMLdiwArDYcOXk1WLc.uWmn8dIhB1GseekHhsTK1DiropVCOGFm7mdmARxvIOGDabOw0yoGbvVUtA
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 01:05:48 am | 1,085 | 4 | 101,690 |
| 01:05:43 am | 1,085 | 50 | 101,686 |
| 01:05:31 am | 1,085 | 111 | 101,636 |
| 01:05:21 am | 1,084 | 14 | 101,525 |
| 01:05:15 am | 1,085 | 4 | 101,511 |
| 01:05:10 am | 1,085 | 158 | 101,507 |
| 01:04:59 am | 1,084 | 45 | 101,349 |
| 01:04:32 am | 1,084 | 46 | 101,304 |
| 01:04:10 am | 1,084 | 3 | 101,258 |
| 01:04:05 am | 1,084 | 20 | 101,255 |
Monthly variations
Annual change
| 2024 | +26.39% | ||
| 2023 | +101.33% | ||
| 2022 | -19.75% | ||
| 2021 | +7.10% | ||
| 2020 | +42.03% | ||
| 2019 | -49.87% | ||
| 2018 | +16.53% | ||
| 2017 | -33.06% | ||
| 2016 | -3.63% | ||
| 2015 | +19.70% | ||
| 2014 | +44.27% | ||
| 2013 | +1.00% | ||
| 2012 | +80.05% | ||
| 2011 | -18.93% | ||
| 2010 | +31.27% | ||
| 2009 | -6.84% | ||
| 2008 | -50.32% | ||
| 2007 | +97.78% | ||
| 2006 | +92.22% | ||
| 2005 | +29.33% | ||
| 2004 | +238.85% | ||
| 2003 | +198.25% | ||
| 2002 | +26.86% | ||
| 2001 | -7.37% | ||
| 2000 | -62.36% |
- Stock Market
- Equities
- GLENMARK Stock
- Quotes Glenmark Pharmaceuticals Limited
